Insiders · Profile

Maryles Joel Michael

Director at Chemomab Therapeutics. Filing since 18 Mar 2022. CIK 0001850990

Company
Date
Role
Action
Shares
Amount
Of holding
24 May 2022
Director
Bought
433
$1.25K
43.3%
18 Mar 2022
Director
Bought
1,000
$4.34K
opened
2 decisions on file.